- Home
- STIM vs FEMY Comparison
STIM vs FEMY Comparison
Compare STIM & FEMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STIM
- FEMY
- Stock Information
- Founded
- STIM 2003
- FEMY 2004
- Country
- STIM United States
- FEMY United States
- Employees
- STIM N/A
- FEMY 34
- Industry
- STIM Medical/Dental Instruments
- FEMY Medical/Dental Instruments
- Sector
- STIM Health Care
- FEMY Health Care
- Exchange
- STIM Nasdaq
- FEMY Nasdaq
- Market Cap
- STIM 29.4M
- FEMY 22.4M
- IPO Year
- STIM 2018
- FEMY 2021
- Fundamental
- Price
- STIM $0.80
- FEMY $0.98
- Analyst Decision
- STIM Buy
- FEMY Strong Buy
- Analyst Count
- STIM 4
- FEMY 3
- Target Price
- STIM $4.67
- FEMY $10.00
- AVG Volume (30 Days)
- STIM 795.3K
- FEMY 263.1K
- Earning Date
- STIM 11-12-2024
- FEMY 11-12-2024
- Dividend Yield
- STIM N/A
- FEMY N/A
- EPS Growth
- STIM N/A
- FEMY N/A
- EPS
- STIM N/A
- FEMY N/A
- Revenue
- STIM $72,711,000.00
- FEMY $1,260,643.00
- Revenue This Year
- STIM $11.40
- FEMY $135.27
- Revenue Next Year
- STIM $12.09
- FEMY $310.75
- P/E Ratio
- STIM N/A
- FEMY N/A
- Revenue Growth
- STIM 5.03
- FEMY 15.33
- 52 Week Low
- STIM $0.52
- FEMY $0.73
- 52 Week High
- STIM $5.07
- FEMY $2.40
- Technical
- Relative Strength Index (RSI)
- STIM 44.61
- FEMY 38.68
- Support Level
- STIM $0.67
- FEMY $0.86
- Resistance Level
- STIM $0.82
- FEMY $1.18
- Average True Range (ATR)
- STIM 0.13
- FEMY 0.09
- MACD
- STIM -0.03
- FEMY -0.03
- Stochastic Oscillator
- STIM 41.54
- FEMY 23.40
About STIM Neuronetics Inc.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.
About FEMY Femasys Inc.
Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics.